Experimental, Molecular Docking and Molecular Dynamics Investigation on Newly Synthesized Diethyl 4-(Anthracen-9-yl)-2,6-Dimethyl-1,4-Dihydropyridine-3,5-Dicarboxylate

The novel compound diethyl 4-(anthracen-9-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate (DHPA) was synthesized via the Hantzsch method. The synthesized compound was studied through FT-IR, FT-Raman, UV-Vis and NMR studies were compared with Density Functional Theory (DFT) calculations using...

Full description

Saved in:
Bibliographic Details
Published inPolycyclic aromatic compounds Vol. 43; no. 7; pp. 5769 - 5784
Main Authors R, Karthick, G, Velraj, A, Karuppusamy, S, Karthikeyan
Format Journal Article
LanguageEnglish
Published Philadelphia Taylor & Francis 09.08.2023
Taylor & Francis Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The novel compound diethyl 4-(anthracen-9-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate (DHPA) was synthesized via the Hantzsch method. The synthesized compound was studied through FT-IR, FT-Raman, UV-Vis and NMR studies were compared with Density Functional Theory (DFT) calculations using the B3LYP exchange-correlation functional to evaluate the synthesized compound. Analyzing the molecular structure of the compound provides more biological information that aids in drug design. Quantum chemical calculations using the DFT method, such as molecular geometry optimization, vibrational assignments, frontier molecular orbitals (FMO), molecular electrostatic potential (MEP) map, natural bond orbitals (NBO), global reactive descriptors, and local reactive descriptors, were performed to analyze the structural characteristics and biological properties of the compound. Finally, molecular docking and molecular dynamics were used to determine the binding interaction and stability of the compound in the docked site. The results from simulation studies suggest that DHPA might be an alternative calcium channel blocker drug.
ISSN:1040-6638
1563-5333
DOI:10.1080/10406638.2022.2106252